The Role of Proprioceptive Deficits, Psychosocial Factors and Inflammation in Pregnancy-related Pelvic Girdle Pain
NCT ID: NCT04226716
Last Updated: 2025-12-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
192 participants
INTERVENTIONAL
2020-06-01
2028-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Symptoms and Function During and After Pregnancy
NCT01787266
Pelvic Girdle Pain in a Pregnant Population in Western Norway.
NCT01098136
Exploring Central Sensitization in Pregnant Women
NCT05507853
Randomized Study on the Evaluation of the Regular Practice of Standardized Postures Stretching Postural® in Secondary Prevention of Low Back Pains During Pregnancy.
NCT03765853
Pelvic Girdle Pain Early Postpartum: Underlying Condition and Associated Factors
NCT03835650
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
Nulliparous women without PPGP will be measured at one timepoint and their data are compared to those of the multiparous women.
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Multiparous, pregnant women
Multiparous women are followed over time and measurements are performed during the first and third pregnancy trimester, and six weeks and six months postpartum.
Assessment of postural control, body perception, psychosocial factors and inflammation
Behavioral assessment of postural control, lumbar proprioceptive use during postural control, back-specific body perception, psychosocial factors (incl. perceived harmfulness of daily activities, pain-related fear of movement, fear-avoidance beliefs, (pregnancy-related) depression, anxiety and stress, optimism/pessimism, pain coping and coping with stressful life events) and inflammatory mediators
Nulliparous women
Nulliparous women are measured at one timepoint and their data are compared to the data of the multiparous women. Nulliparous women who take part in the reliability study are measured twice.
Assessment of postural control, body perception, psychosocial factors and inflammation
Behavioral assessment of postural control, lumbar proprioceptive use during postural control, back-specific body perception, psychosocial factors (incl. perceived harmfulness of daily activities, pain-related fear of movement, fear-avoidance beliefs, (pregnancy-related) depression, anxiety and stress, optimism/pessimism, pain coping and coping with stressful life events) and inflammatory mediators
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Assessment of postural control, body perception, psychosocial factors and inflammation
Behavioral assessment of postural control, lumbar proprioceptive use during postural control, back-specific body perception, psychosocial factors (incl. perceived harmfulness of daily activities, pain-related fear of movement, fear-avoidance beliefs, (pregnancy-related) depression, anxiety and stress, optimism/pessimism, pain coping and coping with stressful life events) and inflammatory mediators
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pregnant of second child or more than second child
* No current PPGP or did not have PPGP during current pregnancy
* Willing to provide written informed consent
* Age- and BMI- matched to pregnant participants
* Nulliparous
* Willing to provide written informed consent
Exclusion Criteria
* Having current PPGP or having had PPGP during the current pregnancy
* History of surgery/major trauma to spine or pelvis
* Surgery/physical trauma to the lower limbs more than two years ago and currently still experiencing symptoms such as pain, instability, or stiffness
* Surgery/physical trauma to the lower limbs less than two years ago
* Specific balance or vestibular disorders
* A medical diagnosis of a rheumatic condition or being under treatment for such a condition by a rheumatologist
* Neurological abnormalities (e.g., peripheral neuropathy)
* Uncorrected visual problems
* Acute ankle problems
* Being on absolute or relative bed rest due to pregnancy-related complications
* Having (had) a formal diagnosis of a psychiatric disorder
* Non-Dutch speaking
* Having low back or pelvic girdle pain at the time of inclusion or in the six months leading up to inclusion
* History of chronic low back or pelvic girdle pain
* History of surgery/major trauma to spine, pelvis and/or lower limbs,
* Specific balance or vestibular disorders
* Spinal deformities
* Rheumatic disease
* Neurological abnormalities
* Acute ankle problems
* (A history of) psychiatric disorders
* Uncorrected visual problems
* Non-Dutch speaking
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ziekenhuis Oost-Limburg
OTHER
Hasselt University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lotte Janssens
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lotte Janssens, PhD, PT
Role: PRINCIPAL_INVESTIGATOR
Hasselt University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hasselt University
Hasselt, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Nina Goossens, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CME ZOL - CTU2019085
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.